scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0272-6386(12)80752-9 |
P698 | PubMed publication ID | 8447309 |
P50 | author | Giuseppe Remuzzi | Q16561003 |
Piero Ruggenenti | Q92877106 | ||
P2093 | author name string | Bellavita P | |
Galbusera M | |||
Cornejo RP | |||
P2860 | cites work | Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group | Q33390678 |
Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura | Q33406293 | ||
Effectiveness of the cryosupernatant fraction of plasma in the treatment of refractory thrombotic thrombocytopenic purpura | Q33407404 | ||
Thrombotic thrombocytopenic purpura: recovery after splenectomy associated with persistence of abnormally large von Willebrand factor multimers | Q33457665 | ||
Treatment of Thrombotic Thrombocytopenic Purpura with Plasma | Q33472076 | ||
The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura | Q33477133 | ||
Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura | Q33481821 | ||
Platelets have more than one binding site for von Willebrand factor | Q33821754 | ||
High molecular weight kininogen is an inhibitor of platelet calpain | Q34578211 | ||
Epidemiology of the Hemolytic Uremic Syndrome | Q57704647 | ||
49 Calcium-activated proteases in mammalian tissues | Q72930592 | ||
P433 | issue | 3 | |
P921 | main subject | thrombocytopenia | Q585285 |
thrombotic thrombocytopenic purpura | Q1426491 | ||
P304 | page(s) | 314-318 | |
P577 | publication date | 1993-03-01 | |
P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
P1476 | title | Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease | |
P478 | volume | 21 |
Q33496688 | Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma |
Q49215238 | ISN Nexus 2016 Symposia: Translational Immunology in Kidney Disease—The Berlin Roadmap. |
Q33495922 | Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury |
Q33346625 | Infectious diseases as a trigger in thrombotic microangiopathies in intensive care unit (ICU) patients? |
Q33496078 | Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy |
Q33490306 | Myeloproliferative and metabolic causes |
Q33497300 | Plasma exchange in a patient with postpartum HELLP syndrome |
Q72171844 | Secondary membranoproliferative glomerulonephritis |
Q33491164 | Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasmapheresis and vincristine |
Q57704288 | The hemolytic uremic syndrome |
Q33335322 | The management of idiopathic thrombotic microangiopathy. Changing trends |
Q33342764 | Thrombotic microangiopathies |
Q57702282 | Thrombotic microangiopathy: What not to learn from a meta-analysis |
Q41475203 | Thrombotic syndromes and autoimmune diseases |
Q33364650 | Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy |
Q33408206 | Thrombotic thrombocytopenic purpura: a case presenting with acute ischemic colitis |
Q33377500 | Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. |
Q81845037 | [Evolution of indications and consumptions of fresh frozen plasma from 1997 to 2003 in a teaching Hospital] |
Q33490200 | alpha 1-Antitrypsin therapy in a case of thrombotic thrombocytopenic purpura |
Search more.